Loading...
Double blind study of ispaghula in irritable bowel syndrome.
A double blind placebo controlled trial of ispaghula husk in 80 patients with irritable bowel syndrome is reported. Global assessment judged treatment to be satisfactory in 82% of patients receiving ispaghula and 53% of the placebo group (p less than 0.02). Bowel habit was unchanged in the placebo g...
Saved in:
Main Authors: | , |
---|---|
Format: | Artigo |
Language: | Inglês |
Published: |
1987
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1433676/ https://ncbi.nlm.nih.gov/pubmed/3322956 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|